ARCHIVES

NCI Seen Shifting Away From Comprehensive Center Emphasis Toward Encouraging Clinical Excellence

This article is from The Cancer Letter archive.

Vol. 02 No. 18 | April 30, 1976

Download PDF Visit The Full Archive

Related Articles

Accrediting Agency Places Dana-Farber On Probation

April 21, 1995

ASCO Growth Changes, Prepare Society for ‘90s

June 8, 1990

Cancer Panel Urges Improved Funding For Basic Science

June 16, 1995

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Army Breast Cancer Research Program Seeks Proposals

March 28, 1997

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009